- GRI Bio (NASDAQ:GRI) on Thursday announced the pricing of a public offering of an aggregate of 2.19M shares of its common stock, Series C-1 warrants to purchase up to 2.19M shares of common stock, and Series C-2 warrants to purchase up to 2.19 85,793 shares of common stock, at a combined public offering price of $1.83 per share and accompanying Series Warrants.
- The series warrants would have an exercise price of $1.83/share and will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares upon exercise of the series warrants.
- The aggregate gross proceeds to the company from the offering are expected to be $4 million.
- GRI +7.104% premarket to $1.96
- Source: Press Release
2024-06-27